Related references
Note: Only part of the references are listed.Pathogenic GRM7 Mutations Associated with Neurodevelopmental Disorders Impair Axon Outgrowth and Presynaptic Terminal Development
Jae-man Song et al.
JOURNAL OF NEUROSCIENCE (2021)
Molecular Co-occupancy Identifies Transcription Factor Binding Cooperativity In Vivo
Can Soenmezer et al.
MOLECULAR CELL (2021)
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
Jonne Lintunen et al.
NPJ SCHIZOPHRENIA (2021)
Update on next generation sequencing of pharmacokinetics-related genes: Development of the PKseq panel, a platform for amplicon sequencing of drug-metabolizing enzyme and drug transporter genes
Koya Fukunaga et al.
DRUG METABOLISM AND PHARMACOKINETICS (2021)
Pharmacogenetics-Guided Advances in Antipsychotic Treatment
Farhana Islam et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Variants in USP48 encoding ubiquitin hydrolase are associated with autosomal dominant non-syndromic hereditary hearing loss
Sissy Bassani et al.
HUMAN MOLECULAR GENETICS (2021)
The missing heritability-Problem in psychiatry: Is the interaction of genetics, epigenetics and transposable elements a potential solution?
Dietrich van Calker et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Review and Consensus on Pharmacogenomic Testing in Psychiatry
Chad A. Bousman et al.
PHARMACOPSYCHIATRY (2021)
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2020)
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
Chiara Fabbri et al.
TRANSLATIONAL PSYCHIATRY (2020)
Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
Wei Liang et al.
TRANSLATIONAL PSYCHIATRY (2020)
Advances in Neurobiology and Pharmacology of GPR12
Gonzalo Allende et al.
FRONTIERS IN PHARMACOLOGY (2020)
PNPT1 and PCGF3 variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide study
Guangyan Mu et al.
PHARMACOGENOMICS (2020)
Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress
Minghua Li et al.
CANCERS (2020)
STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
Marty Chaplin et al.
PLOS MEDICINE (2020)
G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2-and TAB1-TAB3-dependent pathway in endothelial cells
Neil J. Grimsey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
PAC, an evolutionarily conserved membrane protein, is a proton-activated chloride channel
Junhua Yang et al.
SCIENCE (2019)
The regulation, functions and clinical relevance of arginine methylation
Ernesto Guccione et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Identification of TMEM206 proteins as pore of PAORAC/ASOR acid-sensitive chloride channels
Florian Ullrich et al.
ELIFE (2019)
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways
Max Lam et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples
Chiara Fabbri et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Common Disease Is More Complex Than Implied by the Core Gene Omnigenic Model
Naomi R. Wray et al.
CELL (2018)
A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment
Antonio Drago et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2018)
Effect of Damaging Rare Mutations in Synapse-Related Gene Sets on Response to Short-term Antipsychotic Medication in Chinese Patients With Schizophrenia A Randomized Clinical Trial
Qiang Wang et al.
JAMA PSYCHIATRY (2018)
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Peter M. Haddad et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study
Hao Yu et al.
LANCET PSYCHIATRY (2018)
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis
E. Sacchetti et al.
PHARMACOGENOMICS JOURNAL (2017)
The Cost of Relapse in Schizophrenia
Mark Pennington et al.
PHARMACOECONOMICS (2017)
Genome-wide association study of paliperidone efficacy
Qingqin Li et al.
PHARMACOGENETICS AND GENOMICS (2017)
An Expanded View of Complex Traits: From Polygenic to Omnigenic
Evan A. Boyle et al.
CELL (2017)
RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data
Xiaowei Zhan et al.
BIOINFORMATICS (2016)
The Economic Burden of Schizophrenia in the United States in 2013
Martin Cloutier et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
J. M. Stevenson et al.
TRANSLATIONAL PSYCHIATRY (2016)
βII-Spectrin (SPTBN1) Suppresses Progression of Hepatocellular Carcinoma and Wnt Signaling by Regulation of Wnt Inhibitor Kallistatin
Xiuling Zhi et al.
HEPATOLOGY (2015)
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Brendan K. Bulik-Sullivan et al.
NATURE GENETICS (2015)
Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis
Elizabeth Reisinger Walker et al.
JAMA PSYCHIATRY (2015)
Genetic variability in the regulation of gene expression in ten regions of the human brain
Adaikalavan Ramasamy et al.
NATURE NEUROSCIENCE (2014)
Heritability and genetic association analysis of cognition in the Diabetes Heart Study
Amanda J. Cox et al.
NEUROBIOLOGY OF AGING (2014)
Improved whole-chromosome phasing for disease and population genetic studies
Olivier Delaneau et al.
NATURE METHODS (2013)
Evolution of the Vertebrate Paralemmin Gene Family: Ancient Origin of Gene Duplicates Suggests Distinct Functions
Greta Hultqvist et al.
PLOS ONE (2012)
Network-Assisted Investigation of Combined Causal Signals from Genome-Wide Association Studies in Schizophrenia
Peilin Jia et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Pharmacogenomics The Genetics of Variable Drug Responses
Dan M. Roden et al.
CIRCULATION (2011)
Proteins Encoded in Genomic Regions Associated with Immune-Mediated Disease Physically Interact and Suggest Underlying Biology
Elizabeth J. Rossin et al.
PLOS GENETICS (2011)
Rare Variant Association Analysis Methods for Complex Traits
Jennifer Asimit et al.
ANNUAL REVIEW OF GENETICS, VOL 44 (2010)
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries
Ju-Hyun Park et al.
NATURE GENETICS (2010)
Genome-wide association studies in pharmacogenomics
Ann K. Daly
NATURE REVIEWS GENETICS (2010)
DOCK5 and DOCK1 Regulate Caco-2 Intestinal Epithelial Cell Spreading and Migration on Collagen IV
Matthew A. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Finding the missing heritability of complex diseases
Teri A. Manolio et al.
NATURE (2009)
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
Bryan N. Howie et al.
PLOS GENETICS (2009)
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
John McGrath et al.
EPIDEMIOLOGIC REVIEWS (2008)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanism of p38 MAP kinase activation in vivo
D Brancho et al.
GENES & DEVELOPMENT (2003)
ζ-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy
MT Wheeler et al.
HUMAN MOLECULAR GENETICS (2002)
Advances in schizophrenia
GK Thaker et al.
NATURE MEDICINE (2001)
Share Paper
